RDS was a co-sponsor of Advancing Treatments for Alzheimer’s Disease in Individuals with Down Syndrome, held April 15-16, near Washington, D.C. Twelve presentations with follow up panel discussions were grouped in the following areas:
1. Disease Mechanisms
2. Model Systems for Studying Connections between AD and Ds
3. Cognitive Outcomes Measures
5. Developing Therapeutics
For each of the sections, attendees discussed 1) Current strengths and weaknesses in areas of research, 2) What can be done right now to promote research?, and 3) What should be our long term objectives?
This was an extraordinary exchange of ideas from the world’s leading researchers, sharing information on how Ds research might help inform research on AD treatments, and vice versa.
One example of this synergy is the Down Syndrome Biomarker Initiative, in which clinicians will track the brains of people with Down syndrome as they age to learn about healthy brain aging in this population and the potential progression to Alzheimer’s disease. Read about this study here.
[ http://neurosciences.ucsd.edu/centers/down-syndrome-center/research/Pages/c… ]